CASP3 and viral pneumonia: Shen et al used NP and molecular docking simulations to elucidate the mechanisms of action of F1012-2, a novel sesquiterpene lactone from Eupatorium lindleyanum DC., to treat viral pneumonia and identify EGFR, IL-1B, SRC, and CASP3 as promising targets for further development.[9]